Castle Biosciences Inc.

Castle Biosciences provides a suite of advanced gene‑expression diagnostics for dermatologic cancers, uveal melanoma, Barrett’s esophagus, and neuropsychiatric pharmacogenomics, positioning it as a leader in precision oncology and gastroenterology diagnostics.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 823
HQ: Friendswood

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
CSTL	Castle Biosciences Inc. Cap: 1.1B	EQUITY	NGM	USD	US14843C1053	Active	📈